tiprankstipranks
Trending News
More News >
Faes Farma (ES:FAE)
:FAE
Spanish Market

Faes Farma (FAE) Stock Forecast & Price Target

Compare
13 Followers
See the Price Targets and Ratings of:

FAE Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Faes
Farma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FAE Stock 12 Month Forecast

Average Price Target

€5.50
▲(20.61%Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Faes Farma in the last 3 months. The average price target is €5.50 with a high forecast of €5.50 and a low forecast of €5.50. The average price target represents a 20.61% change from the last price of €4.56.
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
Highest Price Target€5.50Average Price Target€5.50Lowest Price Target€5.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Faes Farma

1 Month
No data currently available
3 Months
No data currently available
1 Year
Unknown AnalystJB Capital Markets
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
upgraded a buy rating 2 days ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
No data currently available
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

FAE Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

FAE Financial Forecast

FAE Earnings Forecast

The previous quarter’s earnings for FAE were €0.19.
The previous quarter’s earnings for FAE were €0.19.

FAE Sales Forecast

Next quarter’s sales forecast for FAE is €115.95M with a range of €114.90M to €117.00M. The previous quarter’s sales results were ―. FAE beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year FAE has Outperformed its overall industry.
Next quarter’s sales forecast for FAE is €115.95M with a range of €114.90M to €117.00M. The previous quarter’s sales results were ―. FAE beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.48% of the time in the same period. In the last calendar year FAE has Outperformed its overall industry.

FAE Stock Forecast FAQ

What is ES:FAE’s average 12-month price target, according to analysts?
Based on analyst ratings, Faes Farma’s 12-month average price target is 5.50.
    What is ES:FAE’s upside potential, based on the analysts’ average price target?
    Faes Farma has 20.61% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Faes Farma a Buy, Sell or Hold?
          Faes Farma has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Faes Farma’s share price target?
            The average share price target for Faes Farma is 5.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €5.50 ,and the lowest forecast is €5.50. The average share price target represents 20.61% Increase from the current price of €4.56.
              What do analysts say about Faes Farma?
              Faes Farma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Faes Farma?
                To buy shares of ES:FAE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis